RHC - Morgan Stanley rates the stock as Underweight
PUBLISHED
2022-05-30
Content
Morgan Stanley continues to prefer health insurers over hospitals following the release of recent APRA data. While there has been a deferred premium increase for private health insurance, this is thought to increase the likelihood of membership retention.
Meanwhile, hospital activity in the June quarter to-date has remained subdued. The Underweight rating and $62.00 target for Ramsay Health Care are retained. Industry View: In-Line.
Sector: Health Care Equipment & Services.
Target price is $62.00.Current Price is $77.87. Difference: ($15.87) - (brackets indicate current price is over target). If RHC meets the Morgan Stanley target it will return approximately -26% (excluding dividends, fees and charges - negative figures indicate an expected loss).